2nd DSTU Draft For Comment

This page is part of the FHIR Specification (v0.4.0: DSTU 2 Draft). The current version which supercedes this version is 5.0.0. For a full list of available versions, see the Directory of published versions

Allergy-intolerance-criticality.xml

Raw XML (canonical form)

Definition for Value SetAllergyIntoleranceCriticality

Raw XML

<ValueSet xmlns="http://hl7.org/fhir">
  <id value="allergy-intolerance-criticality"/>
  <meta>
    <lastUpdated value="2015-02-23T09:07:27.665+11:00"/>
    <profile value="http://hl7.org/fhir/Profile/valueset-shareable-definition"/>
  </meta>
  <text>
    <status value="generated"/>
    <div xmlns="http://www.w3.org/1999/xhtml"><!-- Snipped for brevity --></div>
  </text>
  <extension url="http://hl7.org/fhir/ExtensionDefinition/valueset-oid">
    <valueUri value="urn:oid:2.16.840.1.113883.4.642.2.479"/>
  </extension>
  <url value="http://hl7.org/fhir/vs/allergy-intolerance-criticality"/>
  <version value="0.4.0"/>
  <name value="AllergyIntoleranceCriticality"/>
  <publisher value="HL7 (FHIR Project)"/>
  <contact>
    <telecom>
      <system value="url"/>
      <value value="http://hl7.org/fhir"/>
    </telecom>
    <telecom>
      <system value="email"/>
      <value value="fhir@lists.hl7.org"/>
    </telecom>
  </contact>
  <description value="Estimate of the potential clinical harm, or seriousness, of a reaction to an identified
   Substance"/>
  <status value="draft"/>
  <experimental value="false"/>
  <date value="2015-02-23T09:07:27+11:00"/>
  <define>
    <extension url="http://hl7.org/fhir/ExtensionDefinition/valueset-oid">
      <valueUri value="urn:oid:2.16.840.1.113883.4.642.1.479"/>
    </extension>
    <system value="http://hl7.org/fhir/allergy-intolerance-criticality"/>
    <caseSensitive value="true"/>
    <concept>
      <code value="low"/>
      <display value="Low Risk"/>
      <definition value="The potential clinical impact of a future reaction is estimated as low risk: exposure
       to substance is unlikely to result in a life threatening or organ system threatening outcome.
       Future exposure to the Substance is considered a relative contra-indication."/>
    </concept>
    <concept>
      <code value="high"/>
      <display value="High Risk"/>
      <definition value="The potential clinical impact of a future reaction is estimated as high risk: exposure
       to substance may result in a life threatening or organ system threatening outcome. Future
       exposure to the Substance may be considered an absolute contra-indication."/>
    </concept>
    <concept>
      <code value="unassessible"/>
      <display value="Unable to determine"/>
      <definition value="Unable to assess the potential clinical impact with the information available."/>
    </concept>
  </define>
</ValueSet>

Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.